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Abstract: Colloidal suspensions of iron oxide magnetic nanoparticles are known to   dissipate 
energy when exposed to an oscillating magnetic field. Such energy dissipation can be 
employed to locally raise temperature inside a tumor between 41°C and 45°C (hyperthermia) 
to promote cell death, a treatment known as magnetic fluid hyperthermia (MFH). This work 
seeks to   quantify differences between MFH and hot-water hyperthermia (HWH) in terms of 
reduction in cell viability using two cancer cell culture models, Caco-2 (human epithelial 
colorectal   adenocarcinoma) and MCF-7 (human breast cancer). Magnetite nanoparticles were 
  synthesized via the co-precipitation method and functionalized with adsorbed   carboxymethyl 
dextran. Cytotoxicity studies indicated that in the absence of an oscillating magnetic field, cell 
viability was not affected at concentrations of up to 0.6 mg iron oxide/mL. MFH resulted in 
a   significant decrease in cell viability when exposed to a magnetic field for 120 minutes and 
allowed to rest for 48 hours, compared with similar field applications, but with shorter resting 
time. The results presented here suggest that MFH most likely induces apoptosis in both cell 
types. When   compared with HWH, MFH produced a significant reduction in cell viability, and 
these effects appear to be cell-type related.
Keywords: magnetic fluid hyperthermia, carboxymethyl dextran magnetite, cell death, 
apoptosis
Introduction
The physical, chemical, thermal, and mechanical properties of magnetic nanoparticles 
make them suitable for biomedical applications including cell labeling, targeting and 
separation, drug delivery, magnetic resonance imaging, and hyperthermia.1–6 For these 
applications, particles must have combined properties of high magnetic saturation, 
biocompatibility, and suitable functionalization at the surface.7 One promising 
  biomedical approach using magnetic nanoparticles is magnetic fluid hyperthermia 
(MFH), where cancer tissue placed in contact with magnetic nanoparticles is exposed 
to an alternating magnetic field.
During this process, heat is generated due to magnetic hysteresis loss.8 The increase 
in temperature will depend on the magnetic properties of the material, the strength of 
the magnetic field, the frequency of oscillation, and the cooling capacity of the blood 
flow in the tumor site.7 Nanoplatforms such as magnetite-dextran nanoparticles, mag-
netic cationic liposomes, and aminosilane iron oxide nanoparticles have been studied 
in vitro, in vivo, and in human trials, with success.9–16 In humans, treatment was toler-
ated by patients with minor or no side effects, whereas in vivo analysis demonstrated 
successful tumor remission.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Although significant work has been performed in the 
area of MFH in vitro, little has been done to compare the 
effects of MFH with conventional hyperthermia treatments 
such as hot water. Jordan et al were the first to study in vitro 
MFH caused by a suspension of magnetic nanoparticles, and 
compared its effectiveness to hyperthermia using a hot water 
bath.17,18 Results indicated differences regarding the effects 
on the viability of WiDr (human colonic adenocarcinoma) 
and BT-20 (human mammary adenocarcinoma) cells when 
treated by MFH and hot water. Silane-coated nanoparticles 
were used with the BT-20 cells, whereas dextran-coated 
nanoparticles where used with the WiDr cells. Results with 
the WiDr cell line indicated that there was no difference in 
reduction in cell viability for the two treatments, whereas 
the BT-20 cells did demonstrate a significant difference in 
reduction in viability due to MFH when compared with hot-
water hyperthermia (HWH). Such differences are difficult to 
explain when dealing with different cell lines and different 
types of nanoparticle functionalization. Silane-magnetite 
nanoparticles showed higher internalization in BT-20 when 
compared with dextran ferrite particles on WiDr.18 Higher 
levels of magnetic nanoparticle internalization could pro-
mote additional damage and injury to the cells when submit-
ted to a magnetic field, generating a further effect on cell 
viability. Thus, it is unclear whether the observed differences 
are due to the use of two different types of particles or due 
to the differences between cell lines.
Because of the substantial interest in hyperthermia using 
traditional techniques in the clinical literature, and the poten-
tial of MFH to deliver heat locally, potentially avoiding side 
effects associated with regional and systemic forms of hyper-
thermia treatment, there is still interest in direct comparisons 
between hyperthermia and MFH.19–20 This is further motivated 
by debate in the literature as to whether hyperthermia at the 
nanoscale poses any advantages over traditional forms of 
hyperthermia.21 This work seeks to quantify the differences 
between MFH and conventional HWH treatment using a 
temperature range of 41°C−46°C, which is commonly con-
sidered to be the range of hyperthermia. For this purpose, 
two cell models, Caco-2 (human epithelial colorectal adeno-
carcinoma cells) and MCF-7 (human breast cancer cells) 
and one nanoparticle platform composed of co-precipitated 
iron-oxide based magnetic nanoparticles functionalized with 
carboxymethyl dextran, henceforth referred to as IO-CMDX, 
were employed. A series of MFH and hyperthermia exposure 
sequences were designed and performed in both cell lines 
to establish a coherent comparison basis. These scheduled 
treatments took into consideration field exposure time and 
resting times after treatment. Such parameters were varied to 
establish differences. Potential cell death mechanisms, such 
as apoptosis or necrosis, were also investigated.
Materials and methods
Materials for nanoparticle synthesis
Iron (II) chloride tetrahydrate, iron (III) chloride hexahydrate, 
ammonium hydroxide (29% v/v), tetramethylammonium 
hydroxide (25% w/v), and carboxymethyl dextran sodium 
salt were obtained from Sigma Aldrich (St. Louis, MO). 
Nitric acid (HNO3) was obtained from Fisher Scientific 
(Pittsburg, PA).
synthesis of IO-cMDX
Iron oxide nanoparticles were synthesized through 
  co-precipitation of aqueous suspensions of ferric and fer-
rous chloride ions.22 They were then functionalized with 
carboxymethyl dextran to improve particle dispersion in 
cell culture medium. To obtain nanoparticles, an aqueous 
solution of ferric chloride (0.36 M) was vigorously stirred 
with a solution of ferrous chloride (0.18 M), in the presence 
of a nitrogen stream, to avoid oxidation of the iron ions 
prior to precipitation. Ammonium hydroxide was added 
to the iron solution. The product of this reaction quickly 
changed color from brown to black, which is indicative of 
magnetite formation. This solution was heated to 80°C for 
approximately 1 hour under continuous stirring at pH 8.0 to 
promote reduction and precipitation. The solution was left to 
cool overnight. The iron oxide solution was centrifuged for 
5 minutes at 1800 rpm, and the supernatant was discarded. 
The precipitated particles were peptized with 0.5 M HNO3. 
The peptized iron oxide was centrifuged for 15 minutes 
at 3500 rpm and then resuspended in water. A 0.013 M 
solution of carboxymethyl dextran at pH 11.0 was added. 
The final solution was maintained at a pH range of 3.0–5.0 
using 1M HCl. The solution was mixed at 200 rpm for a 
period of 48 hours. The magnetic colloidal suspension was 
washed with an equivalent volume of ethanol at 3500 rpm 
for 10 minutes to precipitate the nanoparticles and remove 
the unattached carboxymethyl dextran. The precipitated 
particles were dialyzed to a conductivity of 10 µS/cm using 
de-ionized water and a dialysis membrane with a molecular 
weight cutoff of 20 kDa. Finally, the nanoparticles were 
dried in a vacuum oven.
Nanoparticle suspension
Nanoparticles were autoclaved for 60 minutes at a tempera-
ture of 121°C and 18 psi. Before experiments with cells, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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particles were suspended in supplemented Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Sigma, St. Louis, 
MO) with phenol red and with 10% of fetal bovine serum 
(FBS) (Invitrogen, Carlsbad, CA). The final particle con-
centration was 10 mg particles/mL (0.6 mg iron oxide/mL). 
For cytocompatibility analysis, four dilutions of 0.3, 0.6, 
0.9, and 1.5 mg iron oxide/mL suspensions in DMEM/FBS 
were   prepared. For MFH, a concentration of 0.6 iron oxide/
mL was used.
Nanoparticle characterization
The weight fraction of iron oxide core in the IO-CMDX 
nanoparticles was determined through thermogravimetric 
analysis using a TA Instruments TA-2950 Thermogravi-
metric Analyzer (TA Instruments, Newcastle, DE) with a 
heating rate of 10°C/min under air flow. The mass fraction 
of iron oxide was calculated from the remnant mass at a 
temperature of 600°C, divided by the initial sample mass. 
The hydrodynamic diameter of the resulting IO-CMDX 
nanoparticles was determined by dynamic light scattering 
(DLS) using a Brookhaven Instruments BI-90Plus Par-
ticle Size Analyzer (90° scattering angle) (Brookhaven 
Instrument Corp, Holtsville, NY). Measurements were 
performed with particles suspended after autoclaving 
using 0.1% w/w suspensions in de-ionized water. The 
capacity of the nanoparticles to dissipate energy as heat 
upon application of an oscillating magnetic field was 
parameterized through the so-called specific absorp-
tion rate (SAR).23 Measurements were made by placing 
1 mL of   IO-CMDX suspension at 0.6 iron oxide/mL in a 
thermally insulated   nonmetallic/nonmagnetic container. 
The sample was allowed to reach thermal equilibrium 
with the surroundings, and then a magnetic field of 20 
kA/m and 238 kHz was applied using a four-turn induc-
tion coil connected to an RDO Induction HFI 3-135/400 
(RDO Enterprises Inc, Washington, NJ). Temperature was 
monitored as a function of time using a ThermoVisionTM 
A20 thermal imaging camera (FLIR   systems, Boston, 
MA). The SAR value of the nanoparticles was calculated 
according to:
SARC
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where C ˆ is the specific heat capacity, assumed equal to that 
of water, msample and miron oxide are the total sample mass and 
iron oxide mass, respectively, and dT/dtt → 0 is the initial 
rate of increase in temperature upon application of the 
magnetic field.
caco-2 cell culture
Caco-2 cells were purchased from the American Type 
Culture Collection (Rockville, MD). Cells were   cultured 
on 75 cm2 cell culture flasks (canted neck) (Costar 
Corning, Lowell, MA) at a concentration of 250,000 cells/
flask, using DMEM containing 10% FBS, 1% nonessen-
tial amino acids   (Invitrogen), 100 units/mL of   penicillin 
(Sigma), and 100 µg/mL of streptomycin (Sigma). Cells 
were maintained in a   controlled   atmosphere at 37°C, 95% 
relative humidity, and 5% CO2. The culture medium was 
changed every other day for   approximately 5–6 days until 
cells reached approximately 80%–90% confluency. Cells 
were detached from the culturing flask by trypsinization, 
resuspended in culture media, and counted.
McF-7 cell culture
MCF-7 cells were purchased from American Type Culture 
Collection (Rockville, MD). Cells were cultured as described 
above, but with a concentration of 1 × 106 cells/flask.
cytocompatibility analysis
Cells were seeded at a concentration of 10,000 cells/cm2 for 
Caco-2 and 40,000 cells/cm2 for MCF-7 in 96-well assay 
plates of 0.71 cm2/well (Costar Corning) and grown for 1 
week in supplemented DMEM with phenol red, with particle 
concentrations of 1.0, 2.0, 3.0, and 5.0 mg/mL at 37°C and 
5% CO2. Pure DMEM was used as a negative control and 
1.5% hypochlorite solution was used as a positive control for 
cell viability. At the end of the week, nanoparticle suspen-
sions were removed and the 96-well assay plate was rinsed 
with Hank’s balanced salt solution (Sigma). For cell viability 
analysis, the cells were incubated at 37°C and 5% CO2 with 
CellTiter-BlueTM (Promega, Madison, WI). Cell viability 
was analyzed with a spectrofluorometer (SpectraMax Gemini 
EM, Molecular Devices, Sunnyvale, CA) with an excita-
tion wavelength of 560 nm and an emission wavelength of 
590 nm required for the aforementioned assay. Cell viability 
results were interpreted as the viability ratio as a function of 
nanoparticle concentration. The viability ratio was calculated 
by normalizing all relative fluorescent unit values with the 
relative fluorescent unit value of the negative control (cells 
with DMEM).
hyperthermia using a hot water bath
Cells were cultured as described. They were detached from 
the culturing flask by trypsinization, resuspended in culture 
media, and counted. A quantity of 3 × 106 cells was seeded on 
a 20 mL test tube and suspended to a final volume of 10 mL International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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with DMEM + 10% FBS. The test tube was then placed in a 
hot water bath at constant temperature (41°C or 45°C) for a 
period of 2 hours. Samples were gently shaken at short time 
intervals. After hyperthermia treatment, the cells’ viability 
was quantified and the presence of apoptotic markers was 
studied as described below.
MFh
Cells were cultured as described above. Cells were detached 
from the culturing flask by trypsinization, resuspended in 
culture media, and counted. A concentration of 3 × 106 cells 
was placed in a 20 mL test tube and suspended to a final 
  volume of 15 mL with DMEM + 10% FBS (negative   control) 
or with a concentration of 0.6 mg/mL of IO-CMDX nano-
particle suspension. The test tube was then inserted into a 
four-turn induction coil connected to an RDO induction 
HFI 3-135/400 (RDO Enterprises Inc, Washington, NJ) and 
bubbled with air to maintain cells suspended during magnetic 
field application.
The magnetic field was applied for a period of 1 hour 
or 2 hours with a magnetic field amplitude of 20 kA/m and 
frequency of 238 kHz. Temperature was monitored using a 
ThermoVisionTM A20 thermal imaging camera (FLIR Systems, 
Boston, MA) and maintained between 42°C and 45°C. Samples 
took an average of 20 minutes to reach the desired temperature, 
after which exposure time started. After the magnetic field 
treatment the cell’s viability and apoptosis were analyzed as 
described below.
cell viability and apoptosis
The effect of hyperthermia on cell culture was analyzed by per-
forming cell viability and testing for the presence of apoptotic 
markers. These assays were performed immediately, 24 hours, 
or 48 hours after hyperthermia application. The assays at 24 
and 48 hours were performed to allow cell death to occur. Cell 
viability was measured by cell-counting using trypan blue. 
Cells were counted before and after hyperthermia application. 
A 1:1 dilution of cell sample and trypan blue dye was used 
for cell counting using a hematocytometer. Stained cells were 
considered dead. Viability results were interpreted as the ratio 
of viable cells after treatment and viable cells before treat-
ment. Final results were normalized with the negative control. 
The presence of apoptotic   markers was analyzed using the 
ApoPercentage assay (Biocolor, County Antrium, UK). This 
assay stains cells when the inner plasma membrane leaflet has 
been exposed, a classic marker of apoptosis. Cells were put in 
contact with the assay with an ApoPercentage concentration of 
5% for a period of 30 minutes. The apoptotic and nonapoptotic 
cells were counted using a hematocytometer. The results were 
interpreted as the apoptosis ratio over the viability ratio.
Data analysis
Unless otherwise stated, the sample size was n = 3. T-test 
(two- tailed distribution, two-sample with unequal   variances) 
analysis was employed to determine any significance 
in observed data. A P-value of ,0.05 was considered 
  statistically significant.
Results
Particle characterization
The hydrodynamic diameter of the IO-CMDX was found 
to be 72.2 ± 4.5 nm according to DLS. Thermogravim-
metric analysis indicated that it consisted of 27% by weight 
  inorganic core and 73% by weight organic material, on the 
basis of the remnant mass after heating to 600°C. The SAR 
of the particles was 245.26 W/g at a magnetic field amplitude 
of 20 kA/m and frequency of 238 kHz. Particle samples were 
also tested for stability in culture media and after autoclav-
ing. Results indicated that particle samples used for hyper-
thermia experiments consisting of a particle concentration 
of 0.6 mg of iron oxide/mL were stable for the experimental 
time frame, and their size in suspension was not affected by 
the autoclaving process. Note that the particles used in this 
study are similar to those reported in our recent work, in 
which additional chemical, physical, and magnetic charac-
terization is provided.24
cytocompatibility
Cytocompatibilty analyses were first performed to rule out 
the effect of nanoparticle toxicity during MFH. Experi-
ments were performed during cell seeding for a period of 
1 week using two different cell culture models (Caco-2 
and MCF-7). Cell viability analysis of IO-CMDX on 
both cell culture lines started to demonstrate cytotoxic 
effects at concentrations above 0.9 mg iron oxide/mL 
(see Figure 1).
MFh and hWh
Two hyperthermia protocols were applied, HWH and MFH, 
with the purpose of comparing traditional hyperthermia with 
that resulting from energy dissipation from magnetic nanopar-
ticles. Experiments were performed to measure the immediate 
and long-term impact of the hyperthermia treatments in cell 
viability using two cell lines, Caco-2 and MCF-7.
HWH experiments were performed at two temperatures, 
41°C and 45°C, with an exposure period of 1 or 2 hours. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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These two temperatures were selected to examine possible 
differences between the minimum and maximum temperature 
of the established hyperthermia range. Cell viability was 
analyzed immediately after application and 24 and 48 hours 
after hyperthermia treatment. Apoptosis analysis was also per-
formed on all treatments to investigate whether hyperthermia 
promoted apoptosis on our cell models. Apoptosis results 
are presented as the ratio between the apoptosis ratio and the 
viability ratio. Magnetic fluid hyperthermia was performed 
by varying the time of magnetic field application, with a mag-
netic field amplitude of 20 kA/m and frequency of 238 kHz. 
Temperature was continuously monitored during magnetic 
field application with an infrared camera and an alcohol 
thermometer. The average temperature recorded during these 
experiments was always between 42°C and 45°C.
To compare the thermal doses supplied to the cells with 
the two treatments, the thermal dose was calculated as 
proposed by Dewey et al.20 The thermal dose in equivalent 
  minutes at 43°C was 420 minutes for HWH and 450   minutes 
for MFH; that is, the HWH protocol actually resulted in 
a slightly higher thermal dose compared with our MFH 
  protocol, when using the equivalent minutes dose metric 
of Dewey.25 However, as discussed below, results indicated 
that for both cell models, MFH induced a more significant 
reduction in cell viability compared with HWH.
Viability and apoptosis analysis using HWH at 41°C on 
cells were performed (data not shown). Data indicated a slight 
decrease in cell viability when compared with the negative 
control. This suggests that hyperthermia at 41°C does not 
cause a significant apoptotic effect in the two cell models used 
in this study. To further investigate the effects of MFH and 
HWH, four different schedules were performed, as follows:
•  Schedule A – analysis immediately after 2-hours 
application
•  Schedule B – analysis performed 24 hours after 2-hours 
application
•  Schedule C – analysis performed 48 hours after 2-hours 
application
•  Schedule D – analysis performed 48 hours after 1-hour 
application.
These schedules were designed to study the immediate 
and long-term effects of HWH and MFH on cell viability and 
apoptosis. Three different controls were always performed 
for each experiment:
•  DMEM – cells maintained in the incubator
•  MF – magnetic field application to cells without 
particles
•  Cytotoxicity – cells in contact with particle suspension 
without the application of a magnetic field.
An average of all the corresponding controls are reported 
and normalized by the results of cells maintained in the 
incubator.
Results indicated that viability of Caco-2 cell controls 
(Figure 2) was over 90% in all cases, and there was no 
statistically significant difference between the experimental 
controls. Apoptosis level was between 20% and 25% 
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Figure 1 Viability analysis of iron oxide nanoparticles coated with carboxymethyl dextran 
as a function of concentration. 
Notes:   corresponds to caco-2 cells and   corresponds to McF-7. each 
bar represents an average of n = 12 ± standard deviation.
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Figure  2  Viability  analysis  of  caco-2  cells  exposed  to  various  modes  of 
hyperthermia. 
Notes:   corresponds to hot water hyperthermia and   corresponds to 
magnetic fluid hyperthermia. Schedule A: Viability measured immediately after 2 hours 
of application; Schedule B: Viability measured 24 hours after 2 hours of application; 
Schedule C: Viability measured 48 hours after 2 hours of treatment; Schedule D: Viability 
measured 48 hours after 1 hour of treatment. *statistically similar with P = 0.62.
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 ( Figure 3) for HWH and MFH. In the case of the MCF-7 
cell line, viability results were also over 90% for all cases 
(Figure 4), and apoptosis levels were approximately 15% 
(Figure 5). Experiments performed using schedule A 
(2-hours application and no resting time) in Caco-2 cells 
showed a decrease in cell viability to ∼85% after HWH and 
to ∼75% after MFH (Figure 3, ‘Schedule A’). When the 
viability was measured 24 hours after 2-hours   hyperthermia 
(schedule B), the HWH treatment did not show any sta-
tistically significant difference (P = 0.62, α = 0.05) when 
compared with HWH using schedule A. A resting time of 
48 hours after hyperthermia resulted in the reduction of cell 
viability to ∼25% for HWH and to ∼2% for MFH (Figure 2, 
‘Schedule C’). Similar experiments were conducted for 
a shorter period of   hyperthermia exposure. Schedule D, 
which consisted of 1 hour of hyperthermia and a resting 
time of 48 hours, had a greater effect on cell viability in both 
methods, HWH and MFH, when compared with schedules 
A and B. A cell viability of ∼65% was obtained for HWH 
and ∼25% for MFH.
Apoptosis analysis was also performed on Caco-2 cells 
after each of the treatments (Figure 3), except for schedule 
C since most cells were dead at that point. Apoptosis after 
HWH was statistically similar for all treatments (P = 0.65, 
α = 0.05) but different from controls, exhibiting an increase 
to ∼35%–40%. On the other hand, for MFH, schedule 
A showed an apoptosis of ∼55%, schedule B an apoptosis 
of ∼35%, and schedule D an apoptosis of ∼70%, which have 
statistically significant differences from the negative control 
(P = 0.02, α = 0.05) and HWH (P = 0.008, α = 0.05).
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Figure 4 Viability analysis of McF-7 cells exposed to various modes of hyperthermia.
Notes:   corresponds to hot water hyperthermia and   corresponds to 
magnetic fluid hyperthermia. Schedule A: Viability measured immediately after 2 hours 
of application; Schedule B: Viability measured 24 hours after 2 hours of application; 
Schedule C: Viability measured 48 hours after 2 hours of treatment; Schedule D: Viability 
measured 48 hours after 1 hour of treatment. *statistically similar with P = 0.15.
Abbreviation: DMEM – cells maintained in the incubator; MF – magnetic field 
application to cells without particles. cytotoxicity – cells in contact with particle 
suspension without the application of a magnetic field.
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Figure 3 Apoptosis ratio over viability ratio for caco-2 cells exposed to various 
modes of hyperthermia. 
Notes:    corresponds  to  hot  water  hyperthermia  and    corresponds 
to magnetic fluid hyperthermia. Schedule A: Viability measured immediately after 
2 hours of application; Schedule B: Viability measured 24 hours after 2 hours of 
application; Schedule D: Viability measured 48 hours after 1 hour of treatment. 
*statistically similar with P = 0.65 when compared to control; **statistically different 
with P = 0.008 when compared to various hot water hyperthermia treatments 
denoted by *; ***statistically different with P = 0.02 when compared those bars 
containing various magnetic hyperthermia treatments denoted by **.
Abbreviation: DMEM – cells maintained in the incubator; MF – magnetic field 
application to cells without particles. cytotoxicity – cells in contact with particle 
suspension without the application of a magnetic field.
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Figure 5 Apoptosis ratio over viability ratio for McF-7 cells exposed to various 
modes of hyperthermia. 
Notes:    corresponds  to  hot  water  hyperthermia  and    corresponds 
to magnetic fluid hyperthermia. Schedule A: Viability measured immediately after 
2 hours of application; Schedule B: Viability measured 24 hours after 2 hours of 
application; Schedule D: Viability measured 48 hours after 1 hour of treatment.
Abbreviation: DMEM – cells maintained in the incubator; MF – magnetic field 
application to cells without particles. cytotoxicity – cells in contact with particle 
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Similar experiments were performed on MCF-7 cells 
in order to establish whether the observed phenomenon 
was specific to the Caco-2 cell line. Results for HWH for 
all of the treatments, except schedule C, demonstrated a 
reduction in cell viability to ∼85%, with no statistically 
significant   difference between treatments (P = 0.15 for 
α = 0.05). HWH using schedule C (2 hours of application 
and a resting time of 48 hours) resulted in a reduction in cell 
viability to ∼45% (see Figure 4). In the case of MFH, there 
was a significant difference in reduction in cell viability for 
schedules A, B, C, and D, for which cell viability decreased 
to ∼80%, ∼50%, ∼5%, and ∼30%, respectively. Apoptosis 
analysis in MCF-7 cells showed an increase to ∼30% for 
schedules A and B and to ∼20% for schedule C after HWH 
(Figure 5). On the other hand, the resulting apoptosis for 
MCF-7 after MFH was ∼25% for schedule A, ∼45% for 
schedule B, and ∼90% for schedule D. Schedule C was not 
measured since most cells were dead.
Discussion
This work intended to quantify differences between conven-
tional hyperthermia (HWH) and MFH. Cytocompatibility 
analysis indicated that there was a reduction in cell viability 
as the amount of iron oxide in suspension increased. This 
reduction in cell viability may be attributed to loss of col-
loidal stability as significant precipitation of the particles 
was observed at higher concentrations. Recently, Miles 
et al26 examined the colloidal stability of nanoparticles in the 
presence of phosphate based buffers. Results demonstrated 
that carboxylic acid groups were displaced by the phosphate 
ions promoting particle aggregation. Since the DMEM for-
mulation possesses a high concentration of phosphate ions 
(0.109 g/L of sodium phosphate monobasic), this was most 
likely the cause for particle aggregation at high concentra-
tions. Loss of viability may be due to potential physical dam-
age caused by precipitated particles. As such, a concentration 
of 0.6 mg iron oxide/mL was selected for MFH experiments 
to ensure that the observed effects were solely due to the 
effects of MFH.
Experimental controls performed on cell viability and 
apoptosis analysis demonstrated that neither magnetic 
nanoparticles alone nor the magnetic field alone affected 
cell viability under the conditions tested. By comparing 
the 1-hour and 2-hours MFH treatments, it was observed 
that there was a difference in viability when measured 
immediately, 24 hours, or 48 hours after treatment. As 
expected, exposure to hyperthermia for 2 hours resulted 
in a greater effect on cell viability when compared with 
exposure for 1 hour. The ability of cells to protect them-
selves from heat stress by producing heat shock proteins 
could be the reason for the need to apply a longer period of 
heat.27 By comparing the results between MFH and HWH, 
it can be observed that there was a greater decrease in cell 
viability with MFH, compared with HWH, for both cell 
types. Jordan et al17,18 reported that WiDr cells treated by 
MFH and HWH did not present a difference in viability, 
whereas BT-20 cells did show a significant difference in cell 
viability after MFH in comparison with HWH. However, 
in their case two different cell models with two different 
particles were employed. As a result, direct comparisons 
are difficult to make. Also, they performed MFH on a cell 
pellet, where only cells on the surface of the pellet will 
have direct contact with the particles. Our experiments were 
conducted with cells in suspension; hence, nanoparticles 
and cells were in direct contact during the treatment. More 
importantly, studies in both cell lines were conducted using 
similarly coated nanoparticles. This allows for a more direct 
comparison between HWH and MFH. Our results indicated 
that for both cell models MFH had a greater effect on cell 
viability when compared with HWH. These results indi-
cate that MFH is an effective tool to target heat to desired 
areas while potentially overcoming current challenges of 
traditional hyperthermia treatments.
Conclusion
This work explored differences between conventional 
hyperthermia (HWH) and MFH. Cytotoxicity experiments 
demonstrated that as colloidal stability was lost, an increase 
in cytotoxic effects was observed when either of the cell 
lines were exposed to IO-CMDX nanoparticles. Subsequent 
experiments were conducted with particle concentrations 
which did not result in loss in cell viability in the absence of 
a magnetic field. HWH experiments suggested that apoptosis 
was induced in both cell models at 45°C. The apoptotic effect 
was slow and its effects on viability were not observed until 
48 hours after 2 hours of treatment. On the other hand, an 
effect due to MFH on cell viability was detected 24 hours 
after 2 hours of treatment, suggesting that MFH had a more 
significant effect on cell viability than HWH. When cell 
viability was compared between HWH and MFH, results 
clearly indicated that there is a significant additional effect 
on cell viability due to MFH when compared with hot water 
treatment, providing additional evidence of the promising 
use of magnetic nanoparticles for localized hyperthermia 
applications. The mechanisms for the observed differences 
are still unknown.International Journal of Nanomedicine
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